Divigel vs. Bijuva

See how Divigel and Bijuva compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Divigel is estrogen-only, so women who still have a uterus usually need a separate progestin, while Bijuva already combines estradiol and progesterone in one capsule.

  • Divigel is a topical gel with four dose strengths for flexible titration, while Bijuva is an oral capsule available in just two strengths.

  • Both treat moderate to severe menopausal hot flashes, but Bijuva's cash price is notably lower than Divigel's typical monthly list price.

Divigel vs. Bijuva Drug Summary

Divigel

Divigel is a topical estradiol gel used to treat moderate to severe hot flashes caused by menopause. It's applied once daily to the thigh and comes in four dose strengths, allowing gradual dose adjustment. It's also used off-label for vaginal dryness and gender-affirming hormone therapy.

Bijuva

Bijuva is an oral capsule combining bioidentical estradiol and progesterone, approved for moderate to severe hot flashes in women with a uterus. It's taken once daily with food, since a high-fat meal increases progesterone absorption. It comes in two dose strengths and is the only FDA-approved single-capsule combination of both hormones.

Divigel vs. Bijuva Side Effects

Divigel

Most common
breast tenderness (>5%)
metrorrhagia (>5%)
vaginal mycosis (>5%)
nasopharyngitis (>5%)

Bijuva

Most common
breast tenderness (up to 10.4%)
headache (up to 4.0%)
nausea (up to 3.5%)
vaginal bleeding (up to 3.4%)

Divigel vs. Bijuva Dosage

Divigel

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.25 g once daily At the start
Maximum dose 1.0 g once daily If needed
Dose changes 3 increases As tolerated

Bijuva

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.5 mg/100 mg once daily At the start
Maximum dose 1 mg/100 mg once daily If needed
Dose changes 1 increase As tolerated

Divigel vs. Bijuva Indications

Divigel

Divigel is FDA-approved to treat moderate to severe hot flashes linked to menopause. It's also used off-label for vaginal dryness and atrophy, and as part of gender-affirming hormone therapy, though the FDA has not reviewed it for those purposes.

  • Moderate to severe menopausal hot flashes (FDA-approved)

  • Vaginal dryness or atrophy (off-label)

  • Gender-affirming hormone therapy (off-label)

  • Not approved for preventing heart disease or dementia

Bijuva

Bijuva is FDA-approved for moderate to severe hot flashes in menopausal women who still have a uterus. The built-in progesterone protects the uterine lining, so it's not intended for women without a uterus.

  • Moderate to severe menopausal hot flashes (FDA-approved)

  • Only approved for women with an intact uterus

  • Not approved for women without a uterus

  • Not approved for preventing heart disease, stroke, or dementia

Divigel vs. Bijuva Pros and Cons

Divigel

Divigel is an estrogen-only gel with four dose strengths, letting clinicians fine-tune how much estrogen a person absorbs. Because it contains no progestin, women who still have a uterus typically need a separate progesterone prescription to guard against endometrial cancer. As a topical product, it also carries a small risk of transferring estrogen to another person through skin contact.

Pros

  • Four dose strengths allow gradual, individualized titration

  • Long track record, FDA-approved since 1975

  • Topical route skips first-pass liver metabolism

  • Can be used off-label for gender-affirming care

Cons

  • Estrogen-only, so a separate progestin is usually needed with a uterus

  • Risk of secondary hormone exposure to children or pets via skin contact

  • Roughly $650 to $900 per month before insurance, more than Bijuva

  • Daily gel application can be messier than taking a pill

Bijuva

Bijuva pairs bioidentical estradiol with bioidentical progesterone in a single daily capsule, so women with a uterus get endometrial protection built in. Because it's swallowed, it passes through the liver, a route linked to a higher risk of blood clots and stroke than transdermal estrogen. It's only available in two dose strengths, giving less room for fine adjustment than a multi-strength gel.

Pros

  • Combines estrogen and progesterone in one capsule, no separate progestin needed

  • Oral capsule avoids the skin-contact exposure risk of gels

  • Roughly $257 to $351 per month cash price, notably less than Divigel

  • Bioidentical hormone formulation matched to the body's own estradiol and progesterone

Cons

  • Only two dose strengths, less flexibility than Divigel's four

  • Oral estrogen is linked to higher clot and stroke risk than transdermal forms

  • Must be taken with food, since a high-fat meal changes absorption

  • Newer to market (2018) with a shorter track record than Divigel

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.